RxDoctor Payments Data

Stephanie Elkins, MD

Family Medicine · Mooresville, NCNPI 1194718403

Payments from drug & device makers

$12,372in general payments, 2019–2025

Across 751 payments — averaging $16.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • AbbVie$1K
  • AstraZeneca$1K
  • GSK$961
  • Pfizer$903
  • Lilly USA, LLC$505
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$12,361100%
  • Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk124$1,667
AbbVie76$1,182
AstraZeneca37$1,025
GSK51$961
Pfizer67$903
Lilly USA, LLC36$505
Amgen27$448
Boehringer Ingelheim26$433
Novartis22$352
Bayer19$342
Johnson & Johnson21$322
Abbott11$239
Amarin Pharma, Inc.15$227
Astellas Pharma US Inc10$221
Takeda Pharmaceuticals U.S.A., Inc.10$181
Merck11$171
Inspire Medical Systems, Inc.2$150
Sumitomo Pharma America, Inc.7$147
Neos Therapeutics, LP10$144
Idorsia Pharmaceuticals US Inc9$140
Eisai Inc.10$137
Lundbeck LLC7$136
Sanofi-aventis U.S. LLC6$130
Kowa Pharmaceuticals America, Inc.8$111
Cranial Technologies, Inc7$107
Teva Pharmaceuticals USA, Inc.7$102
Biohaven Pharmaceutical Holding Company Ltd.6$100
Ironwood Pharmaceuticals, Inc6$96
Esperion Therapeutics, Inc.6$90
Daiichi Sankyo Inc.5$89
Otsuka America Pharmaceutical, Inc.4$85
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$83
Axsome Therapeutics, Inc.4$83
Currax Pharmaceuticals LLC5$70
Heartflow, Inc.1$68
E.r. Squibb & Sons, L.L.C.5$67
IBSA Pharma Inc.4$65
Avion Pharmaceuticals4$60
Amneal Pharmaceuticals LLC4$58
Exact Sciences3$55
Ardelyx, Inc.3$48
Biohaven Pharmaceuticals, Inc.3$46
Dexcom, Inc.2$41
Ironshore Pharmaceuticals Inc.3$40
Hologic Sales And Service, LLC2$37
Scilex Pharmaceuticals Inc.2$37
Almatica Pharma LLC3$35
Adlon Therapeutics L.p.2$34
Arbor Pharmaceuticals, Inc.2$32
Tolmar, Inc.2$32
Bausch Health US, LLC2$29
Hikma Pharmaceuticals USA2$27
Verity Pharmaceuticals Inc.1$24
Corcept Therapeutics1$23
Corium, LLC1$23
Abiomed1$22
Regeneron Healthcare Solutions, Inc.1$20
Organon1$19
Phadia US Inc.1$19
Cipher Pharmaceuticals US LLC1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,372 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$129,244
Medicare patients
407
Services billed
2,148

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban39$44,034
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$38,671
OzempicSemaglutide41$38,555
LinzessLinaclotide22$34,072
JanuviaSitagliptin Phosphate24$28,854
TrulicityDulaglutide15$24,852
JardianceEmpagliflozin20$22,735
XareltoRivaroxaban30$22,575
TradjentaLinagliptin21$20,868
RybelsusSemaglutide11$14,632
Combivent RespimatIpratropium/Albuterol Sulfate17$12,030
MyrbetriqMirabegron11$8,510
Levothyroxine Sodium620$5,498
SynthroidLevothyroxine Sodium61$5,445
SymbicortBudesonide/Formoterol Fumarate20$5,300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat$433$55,63358 claims
Novo NordiskOzempic, Rybelsus$1,667$53,18752 claims
PfizerEliquis, Premarin$903$48,07551 claims
AbbVieLinzess, Synthroid$1,182$39,51783 claims
GSKTrelegy Ellipta$961$38,67146 claims
MerckJanuvia, Lagevrio (Eua)$171$33,85138 claims
Lilly USA, LLCTrulicity$505$24,85215 claims
Johnson & JohnsonXarelto$322$22,57530 claims
Astellas Pharma US IncMyrbetriq$221$8,51011 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$58$5,498620 claims
AstraZenecaSymbicort$1,025$5,30020 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Mooresville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →